发布: 2019年06月05日第9卷第11期 DOI: 10.21769/BioProtoc.3254 浏览次数: 6187
评审: Gal HaimovichVasiliki KoliarakiAnonymous reviewer(s)
相关实验方案
毛细管纳米免疫实验定量分析经CD138筛选的骨髓瘤细胞蛋白
Irena Misiewicz-Krzeminska [...] Norma C. Gutiérrez
2019年06月20日 6113 阅读
Abstract
The recent discovery of human signal peptide peptidase-like 2a (SPPL2a) deficiency in humans revealed the toxicity associated with the accumulation of one of its substrates, CD74 N-terminal fragment (CD74-NTF), for certain type of dendritic cells (cDC2). We developed a two-step protocol for monitoring the accumulation of this molecule in different subsets of PBMCs and immortalized B cells, in which SPPL2a is chemically inhibited and CD74-NTF levels are then assessed by flow cytometry or western blotting. The chemical inhibition of SPPL2a has been described elsewhere, but this is the first time that this inhibition has been reported as a protocol.
Keywords: SPPL2a (SPPL2a)Background
Signal peptide peptidase-like 2A (SPPL2a) is a transmembrane intracellular protease from the GxGD family (Voss et al., 2013). In both humans and mice, the absence of this enzyme results in the accumulation of one of its substrates, CD74 N-terminal fragment (CD74-NTF) in MHC class II-positive cells (Beisner et al., 2013; Bergmann et al., 2013; Schneppenheim et al., 2013; Kong et al., 2018). This accumulated CD74-NTF is selectively toxic to B cells in mice (Beisner et al., 2013; Bergmann et al., 2013; Schneppenheim et al., 2013) and conventional dendritic cells type 2 (cDC2) in both humans (CD1c+ DCs) and mice (CD11c+CD11c+ DCs). We identified the cells most sensitive to CD74-NTF accumulation and gained insight into the mechanism of CD74-NTF-mediated cytotoxicity, using a specific chemical inhibitor of SPPL2a (L-685,458) (Huttl et al., 2015) in peripheral blood mononuclear cells (PBMCs) and Epstein Barr virus-immortalized B cells (EBV-B) from healthy controls. We analyzed CD74-NTF accumulation by fluorescence-activated cell sorting (FACS) or western blotting (WB).
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2019 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Martinez-Barricarte, R., Kong, X. and Casanova, J. (2019). Measurement of CD74 N-terminal Fragment Accumulation in Cells Treated with SPPL2a Inhibitor. Bio-protocol 9(11): e3254. DOI: 10.21769/BioProtoc.3254.
分类
免疫学 > 免疫细胞功能 > 淋巴细胞
免疫学 > 免疫细胞功能 > 树突细胞
生物化学 > 蛋白质 > 免疫检测
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link